Investment Stage

Focus Areas

About Investor

Sangeeta N. Bhatia serves as a Venture Partner at Catalio Capital, where she focuses on seed and Series A investments in BioTech, Drug Delivery, and Diagnostics sectors, with investment ranges typically between $100K and $5.0M, and particular attention to opportunities in Los Angeles/Southern California and Boston/New England regions. Her background includes being Director of the Marble Center for Cancer Nanomedicine at Massachusetts Institute of Technology, with impressive academic credentials including a BSc from Brown University, MD from Harvard Medical School, and PhD from MIT. Bhatia has received numerous prestigious awards and accolades, including the Lemelson-MIT Prize, Heinz Medal, Othmer Gold Medal, and membership in the National Academy of Sciences, National Academy of Medicine, and National Academy of Engineering. She is also a successful entrepreneur, having co-founded multiple companies including Hepregen (now BioVT), Glympse Bio, Satellite Bio, and Impilio Therapeutics, and serves on the Board of Directors of Vertex Pharmaceuticals and Brown University, bringing both scientific expertise and business acumen to her venture capital role.